a-Globin is encoded by the two adjacent genes, al and a2. Although it is clearly established that both a-globin genes are expressed, their relative contributions to a-globin messenger RNA (mRNA) and protein synthesis are not fully defined. Furthermore, changes that may occur in a-globin gene activity secondarily to the loss of function of one or more of these genes (a-thalassemia [Thall) have not been directly investigated. This study further defines the expression of the two human a-globin genes by determining the relative levels of al and a2 mRNA in the reticulocytes of normal individuals and in individuals heterozygous for the common 3.7-kilobase deletion within the a-globin gene cluster that removes the a2-globin gene (the rightward type aThal-2 deletion). To quantitate accurately the ratio of the two a-globin mRNAs, we have modified a previously reported S1 nuclease assay to include the use of 32P end-labeled probes isolated from al-and a2-globin complementary DNA recombinant plasmids. In individuals with a normal a-globin genotype (as determined by Southern blot analysis Iaa/aal), a2-globin mRNA is present at an average 2.8-fold excess to al. In individuals heterozygous for the rightward type a-Thal-2 deletion (-a/aa) the ct2/al mRNA ratio is 1:1. These results suggest that the loss of the a2-globin gene in the a-Thal-2 deletion is associated with a 1.8-fold compensatory increase al-globin gene expression.